Examining Associations of Circulating Endotoxin With Nutritional Status, Inflammation, and Mortality in Hemodialysis Patients

Journal of Renal Nutrition

Volumn 22, Issue 3, 2012, Pages 317-326

  Feroze, Usama ^a   Kalantar Zadeh, Kamyar ^a,b   Sterling, Kevin A ^c   Molnar, Miklos Z ^a   Noori, Nazanin ^a   Benner, Debbie ^c   Shah, Vallabh ^d   Dwivedi, Rama ^c   Becker, Kenneth ^c   Kovesdy, Csaba P ^f   Raj, Dominic S ^c,e  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^e GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ENDOTOXIN; HIGH DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; BLOOD; BODY COMPOSITION; BODY MASS; CIRCULATION; COHORT ANALYSIS; DRUG EFFECT; ENDOTOXEMIA; FEMALE; HUMAN; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PROTEIN CALORIE MALNUTRITION; RENAL REPLACEMENT THERAPY;

ADULT; AGED; BLOOD CIRCULATION; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; COHORT STUDIES; ENDOTOXEMIA; ENDOTOXINS; FEMALE; HUMANS; INFLAMMATION; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; PROTEIN-ENERGY MALNUTRITION; RENAL DIALYSIS;

NEGIBACTERIA;

EID: 84860143575     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2011.05.004     Document Type: Article

References (43)

1. Mailloux L.U., Bellucci A.G., Wilkes B.M., et al. Mortality in dialysis patients: analysis of the causes of death. Am J Kidney Dis 1991, 18:326-335.
2. Sarnak M.J., Jaber B.L. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000, 58:1758-1764.
3. Kessler M., Hoen B., Mayeux D., Hestin D., Fontenaille C. Bacteremia in patients on chronic hemodialysis. A multicenter prospective survey. Nephron 1993, 64:95-100.
4. Hoen B., Paul-Dauphin A., Hestin D., Kessler M. EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998, 9:869-876.
5. Cohen G., Haag-Weber M., Horl W.H. Immune dysfunction in uremia. Kidney Int Suppl 1997, 62:S79-S82.
6. Szeto C.C., Kwan B.C., Chow K.M., et al. Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients. Clin J Am Soc Nephrol 2008, 3:431-436.
7. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science (New York, NY) 1990, 249:1431-1433.
8. Tobias P.S., Soldau K., Ulevitch R.J. Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J Biol Chem 1989, 264:10867-10871.
9. Tobias P.S., Ulevitch R.J. Lipopolysaccharide-binding protein and CD14 in the lipopolysaccharide-dependent activation of cells. Chest 1994, 105(3 suppl):48S-50S.
10. Holzheimer R.G. The significance of endotoxin release in experimental and clinical sepsis in surgical patients-evidence for antibiotic-induced endotoxin release?. Infection 1998, 26:77-84.
11. Mock C.N., Jurkovich G.J., Dries D.J., Maier R.V. Clinical significance of antibiotic endotoxin-releasing properties in trauma patients. Arch Surg 1995, 130:1234-1240. discussion 1240-1231.
12. Van Leeuwen P.A., Boermeester M.A., Houdijk A.P., et al. Clinical significance of translocation. Gut 1994, 35(1 suppl):S28-S34.
13. Arizono K., Nomura K., Motoyama T., et al. Use of ultrapure dialysate in reduction of chronic inflammation during hemodialysis. Blood Purif 2004, 22(suppl 2):26-29.
14. Szeto C.C., Kwan B.C., Chow K.M., et al. Endotoxemia is associated with better clinical outcome in incident Chinese peritoneal dialysis patients: a prospective cohort study. Perit Dial Int 2010, 30:178-186.
15. Stenvinkel P., Alvestrand A. Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial 2002, 15:329-337.
16. Colman S., Bross R., Benner D., et al. The Nutritional and Inflammatory Evaluation in Dialysis patients (NIED) study: overview of the NIED study and the role of dietitians. J Ren Nutr 2005, 15:231-243.
17. Shantouf R.S., Budoff M.J., Ahmadi N., et al. Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients. Am J Nephrol 2010, 31:419-425.
18. Noori N., Kopple J.D., Kovesdy C.P., et al. Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol 2010, 5:2258-2268.
19. Noori N., Kalantar-Zadeh K., Kovesdy C.P., et al. Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clin J Am Soc Nephrol 2010, 5:683-692.
20. Noori N., Kalantar-Zadeh K., Kovesdy C.P., et al. Dietary potassium intake and mortality in long-term hemodialysis patients. Am J Kidney Dis 2010, 56:338-347.
21. Raj D.S., Shah V.O., Rambod M., Kovesdy C.P., Kalantar-Zadeh K. Association of soluble endotoxin receptor CD14 and mortality among patients undergoing hemodialysis. Am J Kidney Dis 2009, 54:1062-1071.
22. Mehrotra R., Kermah D., Fried L., et al. Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes. J Am Soc Nephrol 2007, 18:2781-2788.
23. Beddhu S., Bruns F.J., Saul M., Seddon P., Zeidel M.L. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 2000, 108:609-613.
24. Nelson E.E., Hong C.D., Pesce A.L., et al. Anthropometric norms for the dialysis population. Am J Kidney Dis 1990, 16:32-37.
25. Williams A.J., McArley A. Body composition, treatment time, and outcome in hemodialysis patients. J Ren Nutr 1999, 9:157-162.
26. Kalantar-Zadeh K., Dunne E., Nixon K., et al. Near infra-red interactance for nutritional assessment of dialysis patients. Nephrol Dial Transplant 1999, 14:169-175.
27. Kalantar-Zadeh K., Kuwae N., Wu D.Y., et al. Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr 2006, 83:202-210.
28. Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002, 347:1557-1565.
29. Erbagci A.B., Tarakcioglu M., Aksoy M., et al. Diagnostic value of CRP and Lp in coronary heart disease. Acta Cardiol 2002, 57:197-204.
30. Pecoits-Filho R., Barany P., Lindholm B., Heimburger O., Stenvinkel P. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 2002, 17:1684-1688.
31. Beutler B., Cerami A. The biology of cachectin/TNF-a primary mediator of the host response. Ann Rev Immunol 1989, 7:625-655.
32. McIntyre C.W., Harrison L.E., Eldehni M.T., et al. Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol 2011, 6:133-141.
33. Panichi V., Migliori M., De Pietro S., et al. C reactive protein in patients with chronic renal diseases. Ren Fail 2001, 23:551-562.
34. Zimmermann J., Herrlinger S., Pruy A., Metzger T., Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999, 55:648-658.
35. Chen C.H., Hsu W.H., Chen H.J., et al. Different bacteriology and prognosis of thoracic empyemas between patients with chronic and end-stage renal disease. Chest 2007, 132:532-539.
36. Raetz C.R., Whitfield C. Lipopolysaccharide endotoxins. Ann Rev Biochem 2002, 71:635-700.
37. Rietschel E.T., Kirikae T., Schade F.U., et al. The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology 1993, 187:169-190.
38. Bosshart H., Heinzelmann M. Targeting bacterial endotoxin: two sides of a coin. Ann N Y Acad Sci 2007, 1096:1-17.
39. Wiedermann C.J., Kiechl S., Dunzendorfer S., et al. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol 1999, 34:1975-1981.
40. Goncalves S., Pecoits-Filho R., Perreto S., et al. Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients. Nephrol Dial Transplant 2006, 21:2788-2794.
41. Gordon B.R., Parker T.S., Levine D.M., et al. Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. Crit Care Med 1996, 24:584-589.
42. Levine D.M., Parker T.S., Donnelly T.M., Walsh A., Rubin A.L. In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci U S A 1993, 90:12040-12044.
43. Feingold K.R., Funk J.L., Moser A.H., et al. Role for circulating lipoproteins in protection from endotoxin toxicity. Infect Immun 1995, 63:2041-2046.